TCL Archive $14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists October 24, 1996
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014